ArticleThe Journal of clinical psychiatry2015
Antidepressant use and lifetime history of mental disorders in a community sample: results from the Baltimore Epidemiologic Catchment Area Study.
Article in The Journal of clinical psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- The Role of Natural Products in Treatment of Depressive Disorder.Current neuropharmacology · 2022Article
- Treatment Modalities and Perceived Effectiveness of Treatment Among Adults With Depression.Health services insights · 2020Article
- Depressive disorders: Treatment failures and poor prognosis over the last 50 years.Pharmacology research & perspectives · 2019Review
- Tadalafil Preserves Penile Nitric Oxide Synthase from Detrimental Effect of Paroxetine in Rats.The Eurasian journal of medicine · 2019Article
- Chronic fatigue syndrome in the emergency department.Open access emergency medicine : OAEM · 2019Article
- Utilization of Mental Health Care, Treatment Patterns, and Course of Psychosocial Functioning in Northern German Coronary Artery Disease Patients with Depressive and/or Anxiety Disorders.Frontiers in psychiatry · 2018Article
- Depression as a modifiable factor to decrease the risk of dementia.Translational psychiatry · 2017Article
- National Trends in Antidepressant, Benzodiazepine, and Other Sedative-Hypnotic Treatment of Older Adults in Psychiatric and Primary Care.The Journal of clinical psychiatry · 2017Article
- Trends in Central Nervous System-Active Polypharmacy Among Older Adults Seen in Outpatient Care in the United States.JAMA internal medicine · 2017Article
- Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA.International journal of geriatric psychiatry · 2017Article
- Time Trend in Psychotropic Medication Use in Spain: A Nationwide Population-Based Study.International journal of environmental research and public health · 2016Article
- Case finding and screening clinical utility of the Patient Health Questionnaire (PHQ-9 and PHQ-2) for depression in primary care: a diagnostic meta-analysis of 40 studies.BJPsych open · 2016Review
- Heterogeneity in the prognosis of major depression: from the common cold to a highly debilitating and recurrent illness.Epidemiology and psychiatric sciences · 2015Article
- The effects of S-adenosyl-L-methionine-vitamin B complex on mild and moderate depressive symptoms.HippokratiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivePast studies have shown that many individuals who use antidepressants have no current or lifetime history of mental disorders. However, recent studies suggest that the one-time retrospective evaluation of mental disorders commonly used in such studies may substantially underestimate the true lifetime prevalence of mental disorders. We examined the prevalence of mental disorders, assessed prospectively over multiple interviews, among individuals currently using antidepressants in a community sample.
methodUsing data from the Baltimore Epidemiologic Catchment Area (ECA) Study Wave 1 (1981) through Wave 4 (2004-2005) (N = 1,071), we assessed lifetime prevalence of common mood and anxiety disorders according to DSM-III and DSM-III-R criteria, based on 4 interviews, among participants who reported current antidepressant use. Furthermore, we examined factors associated with current antidepressant use.
resultsThirteen percent of participants at Wave 4 reported currently using antidepressant medications. Among antidepressant users, 69% never met criteria for major depressive disorder (MDD); and 38% never met criteria for MDD, obsessive-compulsive disorder, panic disorder, social phobia, or generalized anxiety disorder in their lifetime. Female gender, Caucasian ethnicity, recent or current physical problems (eg, loss of bladder control, hypertension, and back pain), and recent mental health facility visits were associated with antidepressant use in addition to mental disorders.
conclusionsMany individuals who are prescribed and use antidepressant medications may not have met criteria for mental disorders. Our data indicate that antidepressants are commonly used in the absence of clear evidence-based indications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.